ÂÜÀòÂÒÂ×

Goki Ishikawa serves as the President & CEO of Fujirebio Holdings, leading a global organization in oncology, infectious disease, and neurology immunoassay diagnostics since January 2012. Prior positions include Executive Officer of the IVD Business, President & CEO of Fujirebio Inc., and Representative Director at the same company, notably guiding operations through the pandemic. Goki’s earlier experience encompasses roles such as Director of Product Marketing at Elsevier, where management of a global team was pivotal, and Consultant at The Boston Consulting Group, focusing on healthcare, automobile, and finance sectors. Goki's career began in the Government of Japan as Section Chief after passing the 1st Class Civil Servant Examination. Goki holds an MBA from Harvard Business School and a BA in Economics from The University of Tokyo.